Skip to main content
Emergent BioSolutions Inc. logo

Emergent BioSolutions Inc. — Investor Relations & Filings

Ticker · EBS ISIN · US29089Q1058 LEI · 549300YW6TUOX8BE5103 US Manufacturing
Open in API
Filings indexed 1,264 across all filing types
Latest filing 2016-08-17 Regulatory Filings
Country US United States of America
Listing US EBS

About Emergent BioSolutions Inc.

https://emergentbiosolutions.com/

Emergent BioSolutions Inc. is a life sciences company specializing in solutions for public health threats. The company develops, manufactures, and delivers medical countermeasures for national security and public health preparedness, addressing threats such as anthrax, smallpox, botulism, and Ebola. In addition to its biodefense portfolio, Emergent provides commercial products for endemic health crises, notably the opioid epidemic. The company also offers contract development and manufacturing services through strategic partnerships, leveraging its specialized capabilities to support biopharmaceutical innovators, governments, and non-governmental organizations.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2016
Regulatory Filings
2016-08-17 English
Regulatory Filings 2016
Regulatory Filings
2016-08-17 English
Interim / Quarterly Report 2016
Interim / Quarterly Report Q2 2016
2016-08-05 English
FORM 4/A
Director's Dealing
2016-08-05 English
Regulatory Filings 2016
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes the completion of a distribution of shares (a spin-off) of Aptevo Therapeutics Inc. from Emergent BioSolutions Inc., including details about the Separation and Distribution Agreement, Contribution Agreement, Promissory Note, and related financial arrangements. It also references exhibits such as agreements and unaudited pro forma financial statements. The document is not a full annual or quarterly report, nor is it an earnings release or a proxy statement. It is a regulatory filing announcing a significant corporate event and related agreements. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length (7737 characters) and detailed content support this classification with high confidence.
2016-08-04 English
Earnings Release 2016
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated August 4, 2016, reporting the company's financial and operating results for the period ended June 30, 2016. It specifically states that the full text of the press release is attached as an exhibit. The document itself is short (2360 characters) and primarily serves as a current report announcing the earnings release rather than containing detailed financial statements or analysis. According to the rules, initial announcements of quarterly or periodical financial results (key highlights only) are classified as Earnings Release (ER). This document fits that description as it announces the earnings results and includes a press release as an exhibit.
2016-08-04 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.